References
- A. Gulati and R. Dana, Keratoconjunctivitis sicca, Clinical aspects, in The Cornea (Eds C. S. Foster, D. T. Azar and C. H. Dohlam), 4th ed., Lippincot, Williams and Wilkins, Philadelphia 2005, pp. 603-626.
- R. I. Fox and M. Stern, Sjogren's syndrome: Mechanisms of pathogenesis involve interaction of immune and neurosecretory systems, Scand. J. Rheumatol. 31 (2003) 3-13; DOI: 10.1080/030097402317474874.
- S. C. Pflugfelder, Anti-inflammatory therapy of dry eye, Am. J. Ophthalmol. 137 (2004) 337-342; DOI: 10.1016/J.ajo.2003.10.036.
- L. Libui, D. Li, A. Doshi, W. Farely, R. M. Corrales and S. C. Pflugfelder, Experimental dry eye stimulates the production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface, Invest. Ophthamol. Vis. Sci. 45 (2004) 4293-4301; DOI: 10.1167/iovs.03-1145.
- A. Solomon, D. Dursun and Z. Liu, Pro and anti-inflammatory forms of interleukins in the tear fluid and conjunctiva of patients with dry eye disease, Invest. Ophthamol. Vis. Sci. 42 (2001) 2283-2292.
- T. J. Nagelhaut, D. A. Gamache, L. Roberts, M. T. Brady and J. M. Yanni, Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye, J. Ocul. Pharmacol. Ther. 21 (2005) 139-148; DOI: 10.1089/JOP.2005.21.139.
- L. D. Waterbury, D. Silliman and T. Jalas, Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium, Curr. Med. Res. Opin. 22 (2006) 1133-1140; DOI: 10.1185/03 0079906x112471.
- J. Damm, T. Rau and A. Pah, Constitutive expression and localization of COX-1 and COX-2 in rabbit iris and ciliary body, Exp. Eye Res. 72 (2001) 611-621; DOI: 10.1006/exer.2001.0977.
- A. Bertolini, A. Ottani and M. Sandrini, Selective COX-2 inhibitors and dual acting anti-inflammatory drugs, critical remarks, Curr. Med. Chem. 9 (2002) 1033-1034; DOI: 10.2174/0929867-024606650.
- A. A. Steiner, S. Li, Q. J. Lianos and C. M. Blatteis, Differential inhibition by nimesulide of the early and late phases of intravenous and intracerebral neuroimmunomodulation, 9 (2001) 263-275; DOI: 10.1159/000054289.
- S. Burgalassi, L. Panichi, P. Chetoni, M. F. Saettone and E. Boldrini, Development of a simple dry eye model in the albino rabbit and evaluation of some tear substituents, Ophthalmic Res. 31 (1999) 229-235; DOI: 10.1159/000055537.
- X. U. Li, L. Hu, J. Hu and W. Wang, Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery, Cornea 26 (2007) 516-520; DOI: 10.1097/ico.0b013e31812f67ca.
- L. S. Mengher, A. J. Bron, S. R. Tonge and D. J. Gilbert, Non-invasive instrument for clinical assessment of the precorneal tear film stability, Curr. Eye Res. 4 (1985) 1-7.
- C. Tamer, I. M. Melek, T. Duman and H. Oksuiz, Tear film tests in Parkinson's disease patients, Ophthalmol. 112 (2005) 1795-1800; DOI: 10.1016/J.ophtha.2005.04.025.
- M. D. Sternlicht and Z. Werb, How matrix metalloproteinases regulate cell behavior, Annu. Rev. Cell. Dev. Biol. 17 (2001) 463-516; DOI: 10.1146/annurev.Cellbio.17.1.463.
- D. Dursun, M. Wang, D. Monroy, D. Li, M. E. Stern and S. C. Pflugfelder, A mouse model of KCS, Invest. Ophthamol. Vis. Sci. 43 (2002) 632-638.
- P. Marsh and S. C. Pflugfelder, Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren's syndrome, Ophthalmology 106 (1999) 811-816; DOI: 10.1016/50161-6420(99)90171-9.
- R. Schalnus, Topical non steroidal anti-inflammatory therapy in ophthalmology, Ophthalmologica 217 (2003) 89-98; DOI: 10.1159/000068563.
- S. E. Wilson and H. D. Perry, Long term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment, Ophthalmology 114 (2007) 76-79; DOI: 10.1016/J.ophtha.2006.05.077.